Publicaciones en las que colabora con Pilar Sánchez Gómez (7)

2024

  1. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma

    Journal for immunotherapy of cancer, Vol. 12, Núm. 8

2021

  1. Tumor-derived pericytes driven by egfr mutations govern the vascular and immune microenvironment of gliomas

    Cancer Research, Vol. 81, Núm. 8, pp. 2142-2156

2020

  1. Immune profiling of gliomas reveals a connection with IDH1/2 mutations, tau function and the vascular phenotype

    Cancers, Vol. 12, Núm. 11, pp. 1-18

  2. The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas

    Science Translational Medicine, Vol. 12, Núm. 527

2019

  1. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab

    Clinical and Translational Oncology, Vol. 21, Núm. 10, pp. 1413-1423

  2. Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

    Oxidative medicine and cellular longevity, Vol. 2019, pp. 9719730

2015

  1. Preclinical test of dacomitinib, an irreversible EGFR inhibitor, confirms its effectiveness for glioblastoma

    Molecular Cancer Therapeutics, Vol. 14, Núm. 7, pp. 1548-1558